|
Committees
Executive Committee
Members
| Dr C. CONTINO-PEPIN (University of Avignon, Avignon, France) |
| Prof. P. DALLEMAGNE (University of Caen, Caen, France) |
| Dr G. DURAND (University of Avignon, Avignon, France) |
| Prof. H. GALONS (SCT & Paris Descartes University, Paris, France) |
| Dr P. GEORGE (SCT & Independent Scientific Expert & Adviser, Longvilliers, France) |
| Prof. A. POLIDORI (University of Avignon, Avignon, France) |
| Prof. J. SAPI (SCT & University of Reims-Champagne-Ardenne, Reims, France) |
| Dr L. VAN HIJFTE (SCT & NovAliX, Illkirch, France) |
Local Organising Committee
Members
| Mrs A. BARRIERE (Maison de la Recherche, University of Avignon, Avignon, France) |
| Dr F. BONNETE (CNRS, Institut des Biomolécules Max Mousseron (IBMM)-University of Avignon, Avignon, France) |
| Dr C. CONTINO-PEPIN (University of Avignon, Avignon, France) |
| Dr G. DURAND (University of Avignon, Avignon, France) |
| Dr P. GUILLET (University of Avignon, Avignon, France) |
| Prof. A. POLIDORI (University of Avignon, Avignon, France) |
| Mr S. RAYNAL (University of Avignon, Avignon, France) |
| Mrs V. VIDAU (University of Avignon, Avignon, France) |
Scientific Advisory Board
Members
| Dr J.-L. BANERES (Institut des Biomolécules Max Mousseron (IBMM), Montpellier, France) |
| Prof. R. BUREAU (University of Caen, Caen, France) |
| Dr K. BUSH (Indiana University, Bloomington, United States) |
| Prof. E. M. CARREIRA (ETH Zürich, Zürich, Switzerland) |
| Dr P. CHENE (Novartis, Basel, Switzerland) |
| Dr R. COOKE (Heptares, Hertfordshire, United Kingdom) |
| Dr C. DOUSSON (Idenix Pharmaceuticals, Montpellier, France) |
| Prof. P. DUMY (Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM), Montpellier, France) |
| Prof. E. GIRALT (Institute for Research in Biomedicine (IRB), Barcelona, Spain) |
| Dr J.-C. HARMANGE (Constellation Pharmaceuticals, Cambridge, United States) |
| Dr J.-M. JIMENEZ (Vertex Pharmaceuticals, Abingdon, United Kingdom) |
| Prof. H. KAGECHIKA (Tokyo Medical and Dental University, Tokyo, Japan) |
| Prof. D. KIREEV (University of North Carolina, Chapel Hill, United States) |
| Dr U. LUCKING (Bayer HealthCare, Berlin, Germany) |
| Dr B. MIROUX (University Paris Diderot - Institut de Biologie Physico-Chimique (IBPC), Paris, France) |
| Prof. J. MITTENDORF (Bayer Pharma AG, Wuppertal, Germany) |
| Prof. N. MIYATA (Nagoya City University, Nagoya, Japan) |
| Dr M. MOUREZ (Sanofi-Pasteur, Lyon, France) |
| Dr M. NILGES (Institut Pasteur, Paris, France) |
| Dr M. OKANIWA (Takeda Pharmaceutical Company, Kanagawa, Japan) |
| Dr J.-M. PAGES (Aix Marseille University, Marseille, France) |
| Prof. E. PEBAY-PEYROULA (University Joseph Fourier, Grenoble, France) |
| Prof. J. ROBINSON (University of Zürich, Zürich, Switzerland) |
| Dr H. SHEN (F. Hoffmann-La Roche, Shanghai, China) |
| Dr P. SJÖ (Astrazeneca, Mölndal, Sweden) |
| Prof. H. SUGA (University of Tokyo, Tokyo, Japan) |
| Dr P. P. TAK (GlaxoSmithKline , Brentford, United Kingdom) |
| Dr H. VAN VLIJMEN (Janssen, Beerse, Belgium) |
| Dr R. VAZ (Sanofi-Genzyme, Bridgewater, United States) |
| Prof. S. WANG (University of Michigan, Michigan, United States) |
| Dr G. WECKBECKER (Novartis, Basel, Switzerland) |
| Dr J. Z. ZHU (UCB, Berkshire, United Kingdom) |
|
Organised by
With the support of
EFMC Sponsored Event
Major Sponsors
Sponsors
Media Partners
|